Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Efficacy of Esketamine for Patients With Irritable Bowel Syndrome [NA]

View source ↗

Summary

A clinical trial is assessing the efficacy of esketamine for irritable bowel syndrome and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spravato (esketamine) (esketamine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Irritable Bowel Syndrome | NA | Status: RECRUITING